TickerFacts.

Company research / TMO

Thermo Fisher Scientific Inc. (TMO)

Build a valuation ↗↓ Download CSV

SEC name THERMO FISHER SCIENTIFIC INC. · CIK 0000097745 · NYSE · Measuring & Controlling Devices, NEC

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Thermo Fisher Scientific Inc. reported revenue of $44.56B. Revenue grew 3.9% from the prior annual period. Over the twelve months to 2026-06-27, revenue was $46.34B.

Key ratios (year ended 2025-12-31)

17.4%
Operating margin
15.0%
Net margin
12.6%
Return on year-end equity
3.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-21

Headquarters locality: Waltham · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-27 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-27		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$46.34B$44.56B$42.88B$42.86B$44.91B$39.21B$32.22B$25.54B$24.36B$20.92B$18.27B
Cost of Revenuen/an/an/an/an/an/an/an/an/a$8.98B$8.21B
Gross Profit (computed)n/an/an/an/an/an/an/an/an/a$11.94B$10.06B
R&D Expense$1.40B$1.40B$1.39B$1.34B$1.47B$1.41B$1.18B$1.00B$967.00M$887.00M$754.00M
Operating Income$8.14B$7.75B$7.34B$6.86B$8.39B$10.03B$7.79B$4.59B$3.78B$2.96B$2.46B
Depreciation & Amortizationn/an/an/an/an/an/an/an/a$2.27B$2.03B$1.76B
EBITDAn/an/an/an/an/an/an/an/a$6.05B$4.99B$4.22B
Net Income$6.97B$6.70B$6.33B$6.00Bn/an/an/an/an/an/an/a
EPS (Diluted)n/a$17.74$16.53$15.45$17.63$19.46$15.96$9.17$7.24$5.59$5.09
Total Assets$113.17B$110.34B$97.32B$98.73B$97.15B$95.12B$69.05B$58.38B$56.23B$56.67B$45.91B
Long-Term Debt$42.28B$39.17B$31.07B$34.73B$34.28B$34.67B$21.73B$17.75B$18.99Bn/an/a
Shareholders' Equity$52.68B$53.41B$49.58B$46.73B$43.98B$40.79B$34.51B$29.68B$27.59B$25.41B$21.54B
Cash & Equivalents$4.06B$9.85B$4.01B$8.08B$8.52B$4.48B$10.32B$2.40B$2.10B$1.33B$786.00M
Operating Cash Flow$9.01B$7.82B$8.67B$8.41B$9.15B$9.31B$8.29B$4.97B$4.54B$4.00B$3.26B
Capital Expenditures$1.70B$1.52B$1.40B$1.48B$2.24B$2.52B$1.47B$926.00M$758.00M$508.00M$444.00M
Free Cash Flow$7.32B$6.29B$7.27B$6.93B$6.91B$6.79B$6.82B$4.05B$3.79B$3.50B$2.81B
Share Repurchases$5.00B$3.00B$4.00B$3.00B$3.00B$2.00B$1.50B$1.50B$500.00M$750.00M$1.25B
Dividends Paid$662.00M$636.00M$583.00M$523.00M$455.00M$395.00M$337.00M$297.00M$266.00M$237.00M$238.00M
Dividends Per Sharen/a$1.72$1.56$1.40$1.20$1.04$0.88$0.76$0.68$0.60$0.60
Weighted Average Diluted Sharesn/a378.00M383.00M388.00M394.00M397.00M399.00M403.00M406.00M398.00M397.00M
EPS (Basic)n/a$17.77$16.58$15.52$17.75$19.62$16.09$9.24$7.31$5.64$5.12

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView